Literature DB >> 21600929

Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus.

Tiia Koho1, Leena Huhti, Vesna Blazevic, Kirsi Nurminen, Sarah J Butcher, Pasi Laurinmäki, Nisse Kalkkinen, Gunilla Rönnholm, Timo Vesikari, Vesa P Hytönen, Markku S Kulomaa.   

Abstract

Noroviruses are an important cause of epidemic acute gastroenteritis in humans. In this study the production and characterization of GII.4 norovirus virus-like particles (VLPs) in insect cells is reported. Furthermore, the expression of corresponding norovirus polyhistidine-tagged P domain protein in Escherichia coli is described. The protruding P domain of the norovirus capsid is known to contain determinants for antibody and receptor binding. Therefore, P domain proteins were studied as an alternative diagnostic tool for evaluating norovirus infection. Analyses by dynamic light scattering and cryo-electron microscopy revealed the presence of intact VLPs with an average diameter of about 40 nm. Immunostaining and ELISA assays using norovirus-specific human sera revealed that VLPs and the P domain are recognized by norovirus-specific antibodies and by their putative receptor. The VLPs and P domain protein are potentially useful in the development of diagnostic and vaccination tools for noroviruses.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21600929     DOI: 10.1016/j.jviromet.2011.05.009

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  11 in total

1.  The formation of P particle increased immunogenicity of norovirus P protein.

Authors:  Ming Tan; Xi Jiang
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

Review 2.  Vaccine against norovirus.

Authors:  Ming Tan; Xi Jiang
Journal:  Hum Vaccin Immunother       Date:  2014-05-05       Impact factor: 3.452

3.  A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles.

Authors:  Kirsi Tamminen; Leena Huhti; Tiia Koho; Suvi Lappalainen; Vesa P Hytönen; Timo Vesikari; Vesna Blazevic
Journal:  Immunology       Date:  2012-01       Impact factor: 7.397

4.  Nanobody binding to a conserved epitope promotes norovirus particle disassembly.

Authors:  Anna D Koromyslova; Grant S Hansman
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

5.  A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles.

Authors:  L Huhti; V Blazevic; K Nurminen; T Koho; V P Hytönen; T Vesikari
Journal:  Arch Virol       Date:  2010-08-19       Impact factor: 2.574

6.  Human Norovirus Aptamer Exhibits High Degree of Target Conformation-Dependent Binding Similar to That of Receptors and Discriminates Particle Functionality.

Authors:  Matthew D Moore; Benjamin G Bobay; Brittany Mertens; Lee-Ann Jaykus
Journal:  mSphere       Date:  2016-11-02       Impact factor: 4.389

Review 7.  Norovirus Binding to Ligands Beyond Histo-Blood Group Antigens.

Authors:  Erin A Almand; Matthew D Moore; Lee-Ann Jaykus
Journal:  Front Microbiol       Date:  2017-12-21       Impact factor: 5.640

8.  Nanobodies targeting norovirus capsid reveal functional epitopes and potential mechanisms of neutralization.

Authors:  Anna D Koromyslova; Grant S Hansman
Journal:  PLoS Pathog       Date:  2017-11-02       Impact factor: 6.823

9.  Modular vaccine platform based on the norovirus-like particle.

Authors:  Minna M Hankaniemi; Vesna Blazevic; Vesa P Hytönen; Vili Lampinen; Suvi Heinimäki; Olli H Laitinen; Marko Pesu
Journal:  J Nanobiotechnology       Date:  2021-01-19       Impact factor: 10.435

10.  Secreted production of assembled Norovirus virus-like particles from Pichia pastoris.

Authors:  Jaime Tomé-Amat; Lauren Fleischer; Stephanie A Parker; Cameron L Bardliving; Carl A Batt
Journal:  Microb Cell Fact       Date:  2014-09-10       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.